Upregulation of TRPM8 was observed by Liu et al. to greatly increase the phosphorylation of AKT in breast cancer cells, indicating that the AKT/GSK3β signaling pathway was activated to stimulate the progress of EMT in these cells [45]. The gene discussed is AKT1; the disease is breast carcinoma.